|
(AZN) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
May 21, 2013
(Stock Blog Hub,
5/9/13)
AstraZeneca (AZN) recently announced that it has entered into an agreement with UK-based company, Oxford Cancer Biomarkers Ltd. As per the terms of the agreement, Oxford Cancer...(read more)
(Stock Blog Hub,
4/1/13)
AstraZeneca (AZN) recently announced that it plans to initiate strategic reforms in its research and development (R&D) segment. As per proposed plans, the...(read more)
(Wealth Daily,
4/24/13)
Pharmaceutical company AstraZeneca (NYSE:AZN) is betting big on a small biotech company's technology...
AstraZeneca (AZN) Company Overview
AstraZeneca is one of the world's largest pharmaceutical companies, with FY2009 sales of $32.8 billion and $7.5 billion in profits.[1] AstraZeneca's wide-ranging portfolio of products includes some of the world's most successful drugs. Among other blockbusters, AstraZeneca produces cholesterol fighter Crestor and the ubiquitous "purple pill" Nexium, one of the best-selling drugs in history. (Read more at Wikinvest ) What's in this AZN analysis on Wikinvest...
|
| ||||||||||||||||
